Gastrointestinal Over-The-Counter (OTC) Drugs Global Market Report 2025

Description

Gastrointestinal over-the-counter (OTC) drugs are non-prescription medications used to prevent or treat common digestive issues. They provide quick and convenient relief for problems like indigestion and irregular bowel movements, helping to effectively manage mild to moderate digestive discomfort and promote overall digestive health in a safe and accessible manner.

The primary categories of gastrointestinal OTC drugs include antacids, laxatives, anti-diarrheals, anti-emetics, and others. Antacids are drugs that work by neutralizing stomach acid to alleviate symptoms such as heartburn and indigestion. These medications are available in different forms, including tablets, capsules, liquids, and more, and are used for various conditions like heartburn, diarrhea, constipation, gastroesophageal reflux disease (GERD), nausea, vomiting, motion sickness, and others. They are distributed through multiple channels such as direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and more, and are utilized by key end-users, including hospitals, clinics, home healthcare, and others.

The gastrointestinal OTC drugs market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal OTC drugs market statistics, including the gastrointestinal OTC drugs industry global market size, regional shares, competitors with the gastrointestinal OTC drugs market share, detailed gastrointestinal OTC drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the gastrointestinal OTC drugs industry. This gastrointestinal OTC drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gastrointestinal over-the-counter (OTC) drugs market size has grown strongly in recent years. It will grow from $45.73 billion in 2024 to $49.59 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the increasing prevalence of gastrointestinal disorders, growing consumer inclination toward self-medication, expanded availability of OTC proton pump inhibitors, rising awareness of digestive health, and the growing elderly population susceptible to gastrointestinal issues.

The gastrointestinal over-the-counter (OTC) drugs market size is expected to see strong growth in the next few years. It will grow to $67.88 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to the rising demand for fast-acting symptom relief options, greater penetration of e-commerce pharmacy platforms, increased availability of combination OTC treatments, growing emphasis on gut microbiome health, and intensified marketing and awareness efforts by major industry players. Key trends anticipated during the forecast period include advancements in the formulation of quick-acting antacids, innovation in probiotic-based OTC products, incorporation of herbal ingredients into digestive treatments, improvements in packaging for accurate dosing and portability, and the development of sustained-release gastrointestinal therapies.

The growing prevalence of digestive disorders is expected to drive the expansion of the gastrointestinal OTC drugs market in the coming years. Digestive disorders encompass various conditions affecting the gastrointestinal tract, including the stomach, intestines, and related organs. This rise in digestive issues is primarily linked to increased consumption of processed, low-fiber foods, which negatively impact gut health and digestion. Gastrointestinal OTC medications help alleviate symptoms by neutralizing stomach acid, regulating bowel function, and supporting gut health. They offer quick and convenient relief for common problems such as acidity, constipation, and indigestion. For example, in December 2023, IBD Registry Ltd., a UK-based non-profit organization, reported that the number of individuals diagnosed with inflammatory bowel disease (IBD) surpassed 5,300, representing a rise of over 3,000 compared to 2022. Thus, the increasing occurrence of digestive disorders is fueling the growth of the gastrointestinal OTC drugs market.

Leading companies in the gastrointestinal OTC drugs market are prioritizing the development of advanced products, such as over-the-counter (OTC) proton pump inhibitors (PPIs), to deliver effective and long-lasting relief from acid-related conditions. OTC PPIs are a category of medications available without a prescription that work by reducing stomach acid production. They are frequently used to manage ailments like frequent heartburn, acid reflux (GERD), and gastric ulcers. For example, in March 2025, Eisai Co., Ltd., a pharmaceutical company based in Japan, received approval to convert its Pariet S (rabeprazole sodium 10 mg) from a prescription (RX) to an over-the-counter (OTC) medication. This marked the first OTC PPI in Japan containing the same active ingredient and dosage as its prescription counterpart. Pariet S is used to treat stomach pain, heartburn, and bloating, offering 24-hour relief through a once-daily, easy-to-swallow tablet, and is designed to meet the increasing demand for effective gastric acid-related therapies prompted by lifestyle and demographic changes.

In June 2022, Glenmark Pharmaceuticals Ltd., a pharmaceutical company based in the U.S., acquired select OTC medications from Wockhardt Ltd. for an undisclosed amount. This acquisition is intended to strengthen Glenmark's OTC product portfolio in the U.S. market, with a particular focus on the gastrointestinal segment. Wockhardt Limited, also based in the U.S., is a pharmaceutical company that produces gastrointestinal OTC drugs.

Major players in the gastrointestinal over-the-counter (otc) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd.

North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastrointestinal over-the-counter (OTC) drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastrointestinal over-the-counter (OTC) drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastrointestinal over-the-counter (OTC) drugs market consists of sales of digestive enzymes, probiotics, stool softeners, and fiber supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastrointestinal Over-The-Counter (OTC) Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastrointestinal over-the-counter (otc) drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastrointestinal over-the-counter (otc) drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal over-the-counter (otc) drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Antacid; Laxatives; Anti-Diarrheal; Anti-Emetics; Other Products
2) By Formulation: Tablets; Capsules; Liquids; Other Formulations
3) By Indications: Heartburn; Diarrhoea; Constipation; Gastroesophageal Reflux Disease (GERD); Nausea; Vomiting; Motion Sickness; Other Indications
4) By Distribution Channel: Direct Tender; Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-Users: Hospitals; Clinics; Home Healthcare; Other End-Users
Subsegments:
1) By Antacid: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists; Calcium Carbonate; Magnesium Hydroxide; Sodium Bicarbonate; Combination Antacids
2) By Laxatives: Bulk-Forming Laxatives; Stimulant Laxatives; Osmotic Laxatives; Stool Softeners; Lubricant Laxatives
3) By Anti-Diarrheal: Loperamide; Bismuth Subsalicylate; Probiotics; Electrolyte Solutions
4) By Anti-Emetics: Antihistamines; Bismuth Subsalicylate; Phosphorated Carbohydrate Solution; Ginger Supplements
5) By Other Products: Digestive Enzymes; Antispasmodics; Simethicone; Herbal Remedies; Activated Charcoal
Companies Mentioned: Pfizer Inc.; Procter & Gamble Co.; Johnson & Johnson; Merck & Co. Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r35915

1. Executive Summary

2. Gastrointestinal Over-The-Counter (OTC) Drugs Market Characteristics

3. Gastrointestinal Over-The-Counter (OTC) Drugs Market Trends And Strategies

4. Gastrointestinal Over-The-Counter (OTC) Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Growth Rate Analysis
5.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gastrointestinal Over-The-Counter (OTC) Drugs Total Addressable Market (TAM)

6. Gastrointestinal Over-The-Counter (OTC) Drugs Market Segmentation

6.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antacid
Laxatives
Anti-Diarrheal
Anti-Emetics
Other Products
6.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Liquids
Other Formulations
6.3. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Heartburn
Diarrhoea
Constipation
Gastroesophageal Reflux Disease (GERD)
Nausea
Vomiting
Motion Sickness
Other Indications
6.4. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Direct Tender
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other Distribution Channels
6.5. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Home Healthcare
Other End-Users
6.6. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Antacid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Proton Pump Inhibitors (PPIs)
H2-Receptor Antagonists
Calcium Carbonate
Magnesium Hydroxide
Sodium Bicarbonate
Combination Antacids
6.7. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bulk-Forming Laxatives
Stimulant Laxatives
Osmotic Laxatives
Stool Softeners
Lubricant Laxatives
6.8. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Diarrheal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Loperamide
Bismuth Subsalicylate
Probiotics
Electrolyte Solutions
6.9. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Anti-Emetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Bismuth Subsalicylate
Phosphorated Carbohydrate Solution
Ginger Supplements
6.10. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Digestive Enzymes
Antispasmodics
Simethicone
Herbal Remedies
Activated Charcoal

7. Gastrointestinal Over-The-Counter (OTC) Drugs Market Regional And Country Analysis

7.1. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market

8.1. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastrointestinal Over-The-Counter (OTC) Drugs Market

9.1. China Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
9.2. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastrointestinal Over-The-Counter (OTC) Drugs Market

10.1. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market

11.1. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
11.2. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market

12.1. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market

13.1. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market

14.1. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
14.2. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market

15.1. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
15.2. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market

16.1. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market

17.1. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastrointestinal Over-The-Counter (OTC) Drugs Market

18.1. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market

19.1. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market

20.1. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market

21.1. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
21.2. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market

22.1. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market

23.1. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
23.2. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market

24.1. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
24.2. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market

25.1. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
25.2. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market

26.1. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
26.2. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market

27.1. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market

28.1. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
28.2. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market

29.1. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market Overview
29.2. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gastrointestinal Over-The-Counter (OTC) Drugs Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Landscape And Company Profiles

30.1. Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Landscape
30.2. Gastrointestinal Over-The-Counter (OTC) Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Procter & Gamble Co. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Gastrointestinal Over-The-Counter (OTC) Drugs Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Sanofi S.A.
31.3. AstraZeneca plc
31.4. Abbott Laboratories
31.5. GlaxoSmithKline plc
31.6. Takeda Pharmaceutical Company Limited
31.7. Teva Pharmaceutical Industries Ltd.
31.8. Reckitt Benckiser Group plc
31.9. Boehringer Ingelheim GmbH
31.10. Haleon plc
31.11. Sandoz AG
31.12. Bausch Health Companies Inc.
31.13. Sun Pharmaceutical Industries Ltd.
31.14. Perrigo Company plc
31.15. Dr. Reddy's Laboratories Ltd.

32. Global Gastrointestinal Over-The-Counter (OTC) Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastrointestinal Over-The-Counter (OTC) Drugs Market

34. Recent Developments In The Gastrointestinal Over-The-Counter (OTC) Drugs Market

35. Gastrointestinal Over-The-Counter (OTC) Drugs Market High Potential Countries, Segments and Strategies

35.1 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Gastrointestinal Over-The-Counter (OTC) Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer